Scientists have published over 110 studies on the microbiome in Gulf Cooperation Council countries. These nations include Saudi Arabia, Qatar, Kuwait, the United Arab Emirates, Oman, and Bahrain. The research covers obesity and diabetes, two conditions that affect millions of people in the region. However, the work is not yet ready to change daily life for patients. Most of the studies looked at people rather than testing new treatments. They mostly used a specific gene sequencing method to study gut and oral bacteria. This approach helps identify microbes but does not yet prove how to use them for therapy. The research output is also uneven. Saudi Arabia contributed 44% of all publications. Bahrain and Oman together contributed fewer than 7%. This gap means other nations have less data to build upon. Furthermore, no study combined human, animal, and environmental microbiome research. This One Health approach is vital for food security and sustainability. Animal research focused on camels rather than livestock. Environmental studies looked at soil and desert areas. Without a coordinated strategy, these efforts remain scattered. A unified plan for governance, funding, and workforce development is needed. Only then can the region advance its contribution to global health and help people with obesity and diabetes.
GCC microbiome research is growing but needs a unified regional plan to help people
Photo by National Cancer Institute / Unsplash
What this means for you:
GCC microbiome research is active but needs a unified regional strategy to advance real-world health benefits. More on Diabetes
Review of ADSC-Exos for diabetic foot ulcers lacks reported efficacy data or safety outcomes in this narrative synthesis Stem cell exosomes may help heal diabetic foot ulcers
Frontiers · May 29, 2026
Meta-analysis of CMR biomarkers in diabetes shows elevated ECV and reduced perfusion Heart scans show warning signs in patients with diabetes
Frontiers · May 28, 2026
Systematic review and meta-analysis links COVID-19 infection to 41% higher new-onset diabetes risk Meta-analysis links COVID-19 infection to higher new-onset diabetes risk
Frontiers · May 21, 2026
Systematic review links metabolic dysregulation to impaired oocyte quality and embryonic development potential Metabolic chaos harms egg quality and early embryo growth
Frontiers · May 21, 2026